# Estimating the Prevalence and Genetic Risk Mechanisms of ARFID in a Large Autism Cohort

**Authors:** Tanner Koomar, Taylor R. Thomas, Natalie R. Pottschmidt, Michael Lutter, Jacob J. Michaelson

PMC · DOI: 10.3389/fpsyt.2021.668297 · Frontiers in Psychiatry · 2021-06-09

## TL;DR

This study estimates the prevalence of ARFID in an autism cohort and identifies genetic risk factors, suggesting a lifelong risk and a potential genetic link to autism and other traits.

## Contribution

First genetically-informed investigation of ARFID in a large autism cohort, providing prevalence and heritability estimates and a genome-wide association finding.

## Key findings

- ARFID prevalence in the autism cohort is 21%, higher than previous clinical estimates.
- Narrow-sense heritability for ARFID risk is estimated at 0.45.
- A genome-wide association signal near ZSWIM6 was identified, linked to neurodevelopmental conditions.

## Abstract

This study is the first genetically-informed investigation of avoidant/restrictive food intake disorder (ARFID), an eating disorder that profoundly impacts quality of life for those affected. ARFID is highly comorbid with autism, and we provide the first estimate of its prevalence in a large and phenotypically diverse autism cohort (a subsample of the SPARK study, N = 5,157 probands). This estimate, 21% (at a balanced accuracy 80%), is at the upper end of previous estimates from studies based on clinical samples, suggesting under-diagnosis and potentially lack of awareness among caretakers and clinicians. Although some studies suggest a decrease of disordered eating symptoms by age 6, our estimates indicate that up to 17% (at a balanced accuracy 87%) of parents of autistic children are also at heightened risk for ARFID, suggesting a lifelong risk for disordered eating. We were also able to provide the first estimates of narrow-sense heritability (h2) for ARFID risk, at 0.45. Genome-wide association revealed a single hit near ZSWIM6, a gene previously implicated in neurodevelopmental conditions. While, the current sample was not well-powered for GWAS, effect size and heritability estimates allowed us to project the sample sizes necessary to more robustly discover ARFID-linked loci via common variants. Further genetic analysis using polygenic risk scores (PRS) affirmed genetic links to autism as well as neuroticism and metabolic syndrome.

## Linked entities

- **Genes:** ZSWIM6 (zinc finger SWIM-type containing 6) [NCBI Gene 57688]
- **Diseases:** ARFID (MONDO:7770002), autism (MONDO:0005260), metabolic syndrome (MONDO:0000816)

## Full-text entities

- **Genes:** ZSWIM6 (zinc finger SWIM-type containing 6) [NCBI Gene 57688] {aka AFND, NEDMAGA}, WDR3 (WD repeat domain 3) [NCBI Gene 10885] {aka DIP2, UTP12}, Aldh3a1 (aldehyde dehydrogenase family 3, subfamily A1) [NCBI Gene 11670] {aka Ahd-4, Ahd4, Aldh, Aldh3}, Ulk2 (unc-51 like kinase 2) [NCBI Gene 29869] {aka A830085I22Rik, Unc51.2, mKIAA0623}, ULK2 (unc-51 like autophagy activating kinase 2) [NCBI Gene 9706] {aka ATG1B, Unc51.2}, SPAG17 (sperm associated antigen 17) [NCBI Gene 200162] {aka CT143, PF6, SPGF55}, GDAP2 (ganglioside induced differentiation associated protein 2) [NCBI Gene 54834] {aka MACROD3, SCAR27}, Thsd7a (thrombospondin, type I, domain containing 7A) [NCBI Gene 330267] {aka Gm837}, THSD7A (thrombospondin type 1 domain containing 7A) [NCBI Gene 221981], GPATCH2 (G-patch domain containing 2) [NCBI Gene 55105] {aka CT110, GPATC2, PPP1R30, Pfa1}, SPATA17 (spermatogenesis associated 17) [NCBI Gene 128153] {aka CFAP305, FAP305, IQCH, MOT17, MSRG-11, MSRG11}, WARS2 (tryptophanyl tRNA synthetase 2, mitochondrial) [NCBI Gene 10352] {aka NEMMLAS, PKDYS3, TrpRS, mtTrpRS}, TBX15 (T-box transcription factor 15) [NCBI Gene 6913] {aka TBX14}
- **Diseases:** neuropsychiatric and morphological (MESH:C000631768), RRBs (MESH:D002313), weight gain (MESH:D015430), intellectual disability (MESH:D008607), Developmental Coordination Disorder (MESH:D019957), GIH (MESH:D005767), metabolic syndrome (MESH:D024821), anxiety disorders (MESH:D001008), anorexia nervosa (MESH:D000856), GI (MESH:D006470), IBD (MESH:D015212), Cognitive impairment (MESH:D003072), food allergies (MESH:D005512), Anxiety over eating (MESH:D001007), ADHD (MESH:D001289), malnutrition (MESH:D044342), neurodevelopmental conditions (MESH:D020763), schizophrenia (MESH:D012559), IBS (MESH:D053560), GI symptoms (MESH:D012816), disordered eating (MESH:D001068), anorexia (MESH:D000855), developmental disorders (MESH:D002658), Autism (MESH:D001321), problems with bowel movements (MESH:D012778), irritable bowel syndrome (MESH:D043183), thinness (MESH:D013851), bulimia (MESH:D002032), /Restrictive Food Intake Disorder (MESH:D000080146), vomiting (MESH:D014839), MDD (MESH:D003865), internalizing problems (MESH:D000082122), behaviors (MESH:D001523), constipation (MESH:D003248), eating and gastrointestinal problems (MESH:D012817), autism spectrum disorder (MESH:D000067877), bipolar disorder (MESH:D001714), GI distress (MESH:D012128)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs73984121, rs13177031, rs1575620, rs78495856, rs78624779

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8221394/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8221394/full.md

## References

68 references — full list in the complete paper: https://tomesphere.com/paper/PMC8221394/full.md

---
Source: https://tomesphere.com/paper/PMC8221394